Inspire Medical Systems
Tracked across 11 events · 82 articles · First seen Nov 13, 2025 · Last active Aug 12, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Inspire Medical Systems is facing a securities fraud class action lawsuit due to alleged misrepresentations regarding the launch of its Inspire V device, which led to a significant stock drop.
Nov 13, 2025 · 20 articles
Regulatory
Impact: Inspire Medical Systems, Inc. is facing a federal securities class action lawsuit due to alleged false and misleading statements regarding the launch of its Inspire V device, which led to a significant drop in its stock price and market capitalization.
Nov 20, 2025 · 6 articles
Business
Impact: Inspire Medical Systems is facing a securities class action lawsuit for allegedly misleading investors about the launch of its Inspire V device, leading to a significant stock price drop and reduced earnings guidance.
Nov 17, 2025 · 6 articles
Business
Impact: Inspire Medical Systems shareholders elected Scott R. Ward to its Board of Directors, which is expected to bring valuable industry experience and strategic insight for long-term growth.
May 19, 2026 · 6 articles
Business
Impact: Inspire Medical Systems announced the dates for its Q1 and Q2 2026 financial results releases and investor conference calls. This event is a routine disclosure for the company.
Apr 02, 2026 · 8 articles
Business
Impact: Inspire Medical Systems, a medical technology company, announced it will release its second quarter 2026 financial results and host a conference call to discuss them. This event is a routine financial disclosure for the company.
Jul 06, 2026 · 6 articles
Regulatory
Impact: Inspire is the subject of the investigation and lawsuit, facing allegations of securities law violations and fiduciary breaches.
Jun 29, 2026 · 6 articles
Business
Impact: CMS expands its CNS pipeline through a second collaboration with Insilico, leveraging its clinical and commercial infrastructure to advance AI-discovered drug candidates.
Jul 13, 2026 · 6 articles
Business
Bicara Therapeutics, an AI-driven drug discovery company based in Chengdu, China, announced the successful closing of an oversubscribed Series A financing round, raising nearly $30 million. The round was co-led by Legend Holdings and Shanghai…
Impact: Inspire Medical Systems participated in the financing, gaining exposure to Beyang's innovative pipeline. This strategic investment may complement its existing pharmaceutical portfolio.
Jul 20, 2026 · 6 articles
Business
Impact: Varian is mentioned as a prior business unit where John Kowal served.
Jul 30, 2026 · 6 articles
Business
Impact: Inspire Medical Systems is mentioned as a current board seat for McDonnell; no direct impact.
Jul 08, 2026 · 6 articles
70
Inspire Medical Systems participated in financing Bicara TherapeuticsBeyang Therapeutics closes...
ERGEN INTELLIGENCE
Track Inspire Medical Systems live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard